Clinical Trial Update: Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating recurrence score-guided chemotherapy in HR-positive, HER2-negative breast cancer after neoadjuvant therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN